170 related articles for article (PubMed ID: 17678662)
1. Quantitative and clinical description of postural instability in women with breast cancer treated with taxane chemotherapy.
Wampler MA; Topp KS; Miaskowski C; Byl NN; Rugo HS; Hamel K
Arch Phys Med Rehabil; 2007 Aug; 88(8):1002-8. PubMed ID: 17678662
[TBL] [Abstract][Full Text] [Related]
2. The alteration of static and dynamic postural stability among women with breast cancer during taxane-based chemotherapy: a descriptive study.
Rattanakrong N; Siriphorn A; Boonyong S
Physiother Theory Pract; 2024 Jun; 40(6):1172-1180. PubMed ID: 36305704
[TBL] [Abstract][Full Text] [Related]
3. Impaired Postural Control and Altered Sensory Organization During Quiet Stance Following Neurotoxic Chemotherapy: A Preliminary Study.
Monfort SM; Pan X; Loprinzi CL; Lustberg MB; Chaudhari AMW
Integr Cancer Ther; 2019; 18():1534735419828823. PubMed ID: 30741022
[TBL] [Abstract][Full Text] [Related]
4. Natural history of postural instability in breast cancer patients treated with taxane-based chemotherapy: A pilot study.
Monfort SM; Pan X; Patrick R; Singaravelu J; Loprinzi CL; Lustberg MB; Chaudhari AMW
Gait Posture; 2016 Jul; 48():237-242. PubMed ID: 27341530
[TBL] [Abstract][Full Text] [Related]
5. Neuropathic pain and balance problems are poorly evaluated in patients receiving taxane-based chemotherapy.
J Support Oncol; 2005; 3(6):412. PubMed ID: 16350427
[No Abstract] [Full Text] [Related]
6. Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients.
Monfort SM; Pan X; Patrick R; Ramaswamy B; Wesolowski R; Naughton MJ; Loprinzi CL; Chaudhari AMW; Lustberg MB
Breast Cancer Res Treat; 2017 Jul; 164(1):69-77. PubMed ID: 28374323
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular risk profile of patients with HER2/neu-positive breast cancer treated with anthracycline-taxane-containing adjuvant chemotherapy and/or trastuzumab.
Jones LW; Haykowsky M; Peddle CJ; Joy AA; Pituskin EN; Tkachuk LM; Courneya KS; Slamon DJ; Mackey JR
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1026-31. PubMed ID: 17507633
[TBL] [Abstract][Full Text] [Related]
8. Colored body images reveal the perceived intensity and distribution of pain in women with breast cancer treated with adjuvant taxanes: a prospective multi-method study of pain experiences.
Hellerstedt-Börjesson S; Nordin K; Fjällskog ML; Rissanen R; Peterson M; Arving C
Scand J Pain; 2018 Oct; 18(4):581-591. PubMed ID: 29949517
[TBL] [Abstract][Full Text] [Related]
9. Taxane effect in a bladder washing.
Dustin SM; Jeffus SK; Stelow EB
Diagn Cytopathol; 2015 Jan; 43(1):32-3. PubMed ID: 24644138
[No Abstract] [Full Text] [Related]
10. GM1 for taxane-induced neuropathy in breast cancer.
Das M
Lancet Oncol; 2019 Jul; 20(7):e348. PubMed ID: 31130320
[No Abstract] [Full Text] [Related]
11. Are pharmacogenomic biomarkers an effective tool to predict taxane toxicity and outcome in breast cancer patients? Literature review.
De Iuliis F; Salerno G; Taglieri L; Scarpa S
Cancer Chemother Pharmacol; 2015 Oct; 76(4):679-90. PubMed ID: 26198313
[TBL] [Abstract][Full Text] [Related]
12. Drug evaluation: Bay-59-8862.
Eckstein JW
IDrugs; 2004 Jun; 7(6):575-81. PubMed ID: 15197663
[TBL] [Abstract][Full Text] [Related]
13. β3-tubulin is a good predictor of sensitivity to taxane-based neoadjuvant chemotherapy in primary breast cancer.
Xiang Y; Yang Y; Guo G; Hu X; Zhang H; Zhang X; Pan Y
Clin Exp Med; 2016 Aug; 16(3):391-7. PubMed ID: 26088183
[TBL] [Abstract][Full Text] [Related]
14. Maternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literature.
Cardonick E; Bhat A; Gilmandyar D; Somer R
Ann Oncol; 2012 Dec; 23(12):3016-3023. PubMed ID: 22875836
[TBL] [Abstract][Full Text] [Related]
15. Evidence-based use of neoadjuvant taxane in operable and inoperable breast cancer.
Estévez LG; Gradishar WJ
Clin Cancer Res; 2004 May; 10(10):3249-61. PubMed ID: 15161677
[TBL] [Abstract][Full Text] [Related]
16. Taxane-induced scleroderma.
Itoh M; Yanaba K; Kobayashi T; Nakagawa H
Br J Dermatol; 2007 Feb; 156(2):363-7. PubMed ID: 17223879
[TBL] [Abstract][Full Text] [Related]
17. Randomized sham-controlled pilot trial of weekly electro-acupuncture for the prevention of taxane-induced peripheral neuropathy in women with early stage breast cancer.
Greenlee H; Crew KD; Capodice J; Awad D; Buono D; Shi Z; Jeffres A; Wyse S; Whitman W; Trivedi MS; Kalinsky K; Hershman DL
Breast Cancer Res Treat; 2016 Apr; 156(3):453-464. PubMed ID: 27013473
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylated/activated HER2 as a marker of clinical resistance to single agent taxane chemotherapy for metastatic breast cancer.
Modi S; DiGiovanna MP; Lu Z; Moskowitz C; Panageas KS; Van Poznak C; Hudis CA; Norton L; Tan L; Stern DF; Carter D; Seidman AD
Cancer Invest; 2005; 23(6):483-7. PubMed ID: 16203655
[TBL] [Abstract][Full Text] [Related]
19. Effects of chemotherapy process on postural balance control in patients with breast cancer.
Bahcaci U; Demirbuken I
Indian J Cancer; 2019; 56(1):50-54. PubMed ID: 30950445
[TBL] [Abstract][Full Text] [Related]
20. [Acute typhlitis associated with taxane-based chemotherapy].
Gagliano E; Tonante A; Taranto F; Mamo M; Sturniolo G; Colonese F; Sturniolo G
G Chir; 2010; 31(11-12):514-7. PubMed ID: 21232195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
